Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.0928 EUR -2.32%
Market Cap: 17.7m EUR

Operating Margin
Gensight Biologics SA

-7 835.1%
Current
-2 210%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7 835.1%
=
Operating Profit
-15.2m
/
Revenue
194k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Gensight Biologics SA
PAR:SIGHT
17.7m EUR
-7 835%
IL
Can Fite Biopharma Ltd
TASE:CANF
169.9T ILS
-1 487%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
390.1B USD
33%
US
Amgen Inc
NASDAQ:AMGN
174.5B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
151.2B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.5B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD
28%
AU
CSL Ltd
ASX:CSL
84B AUD
26%
NL
argenx SE
XBRU:ARGX
42.7B EUR
22%
No Stocks Found

Gensight Biologics SA
Glance View

Market Cap
17.7m EUR
Industry
Biotechnology

GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

SIGHT Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7 835.1%
=
Operating Profit
-15.2m
/
Revenue
194k
What is the Operating Margin of Gensight Biologics SA?

Based on Gensight Biologics SA's most recent financial statements, the company has Operating Margin of -7 835.1%.

Back to Top